このページは自動翻訳されたものであり、翻訳の正確性は保証されていません。を参照してください。 英語版 ソーステキスト用。

Effects of TMS-tACS on Central Autonomic Coupling and Cognition

2026年11月11日 更新者:Xidian University

Modulatory Effects of Combined TMS-tACS Stimulation on Central Autonomic Coupling and Cognitive Function

This study investigates the effects of combined transcranial magnetic stimulation (TMS) and transcranial alternating current stimulation (tACS) on cognitive function and brain-visceral coupling in healthy adults, while exploring the underlying neural mechanisms. Participants will undergo four different neuromodulation conditions, including TMS stimulation, tACS stimulation, combined TMS-tACS stimulation, and sham stimulation. The order of stimulation sessions will be counterbalanced using a randomized Latin square design. During each experimental session, researchers will simultaneously record participants' electroencephalography (EEG), electrocardiography (ECG), respiratory, and gastric signals before and after stimulation, and evaluate cognitive performance through behavioral tasks following stimulation. The primary objective of this study is to investigate how different neuromodulation patterns influence brain-visceral coupling and cognitive function, and to further examine the relationship between changes in central-autonomic interactions and cognitive performance. The findings may provide experimental evidence for understanding the neural mechanisms underlying cognitive regulation and optimizing future non-invasive neuromodulation approaches.

調査の概要

詳細な説明

This is an exploratory, randomized, single-blind, sham-controlled, within-subject crossover study designed to investigate the regulatory effects of combined transcranial magnetic stimulation (TMS) and transcranial alternating current stimulation (tACS) on cognitive function and brain-visceral coupling, as well as the underlying neural mechanisms in healthy adults.

Participants will undergo four experimental stimulation conditions, including TMS stimulation, tACS stimulation, combined TMS-tACS stimulation, and sham stimulation. The order of the four stimulation conditions will be balanced using a Latin square design to minimize potential sequence effects, learning effects, and carry-over effects between conditions. A minimum interval of one week will be maintained between experimental sessions. Before stimulation, participants will undergo safety screening and resting motor threshold (RMT) assessment, which will be used to determine individualized stimulation parameters.

During each experimental session, researchers will simultaneously record multimodal physiological signals, including electroencephalography (EEG), electrocardiography (ECG), respiratory signals, and gastric electrical activity, before and after stimulation. Following the intervention, participants will complete cognitive assessment tasks to evaluate changes in cognitive performance induced by different neuromodulation conditions. Participants will not be informed of the specific stimulation condition received in each session to ensure the objectivity and scientific validity of the study.

Primary outcome measures include: brain-visceral coupling metrics, which characterize bidirectional interactions between central neural activity and autonomic physiological rhythms; heartbeat-evoked potentials (HEP), an EEG component time-locked to ECG R-peaks that reflects cortical processing of cardiac afferent information and interoceptive function; heart rate variability (HRV), which reflects autonomic nervous system regulation; and EEG oscillatory activity, which evaluates changes in neural rhythmic dynamics induced by stimulation. Cognitive performance measures will also be collected to investigate the relationship between alterations in brain-visceral coupling and cognitive function.

The primary objective of this study is to systematically examine how different neuromodulation patterns, including TMS, tACS, and combined TMS-tACS stimulation, influence brain-visceral coupling and cognitive function, and to further explore the association between central-autonomic interactions and cognitive performance. The findings may provide experimental evidence for understanding the mechanisms of brain-body interaction and optimizing future non-invasive neuromodulation approaches for cognitive enhancement.

研究の種類

介入

入学 (推定)

30

段階

  • 適用できない

連絡先と場所

このセクションには、調査を実施する担当者の連絡先の詳細と、この調査が実施されている場所に関する情報が記載されています。

研究連絡先

研究場所

    • Shaanxi
      • Xi'an、Shaanxi、中国、71000
        • 募集
        • Xidian University
        • コンタクト:

参加基準

研究者は、適格基準と呼ばれる特定の説明に適合する人を探します。これらの基準のいくつかの例は、人の一般的な健康状態または以前の治療です。

適格基準

就学可能な年齢

18年~55年 (大人)

健康ボランティアの受け入れ

はい

受講資格のある性別

全て

説明

Inclusion Criteria

  1. Age between 18 and 55 years.
  2. Right-handed individuals.
  3. Body mass index (BMI) between 18 and 24.
  4. No contraindications to transcranial magnetic stimulation (TMS).
  5. No history of clinically significant cardiac disease.
  6. No gastrointestinal disorders.
  7. No respiratory system disorders.
  8. No ear-related diseases.
  9. Voluntary participation and provision of written informed consent.
  10. No participation in other neuromodulation studies within the past month.
  11. Ability to understand the experimental procedures and complete cognitive tasks as required.

Exclusion Criteria

  1. History of epilepsy, traumatic brain injury, severe headache, brain surgery, or other neurological disorders.
  2. History of psychiatric disorders, cognitive impairment, or recent use of medications that may affect central nervous system excitability, including sedatives, antidepressants, or stimulants.
  3. Presence of any contraindications to TMS, including metallic implants, cardiac pacemakers, implantable electronic devices, cochlear implants, or other implanted devices.
  4. Infection, inflammation, ulceration, skin lesions, allergy, reduced sensation, or structural abnormalities of the external ear or stimulation sites.
  5. History of vagus nerve injury or related surgical procedures.
  6. History of cardiovascular diseases, respiratory diseases, gastrointestinal ulcers, or other medical conditions that may affect experimental safety or study outcomes.
  7. Bilateral hand dysfunction preventing completion of experimental tasks.
  8. Current smoking, long-term substance dependence, or recent conditions that may influence study outcomes, such as severe sleep deprivation, alcohol consumption, or excessive fatigue.
  9. Recent participation in other neuromodulation-related experiments.
  10. Refusal to sign the informed consent form.
  11. Any other conditions considered unsuitable for participation by the investigators.

研究計画

このセクションでは、研究がどのように設計され、研究が何を測定しているかなど、研究計画の詳細を提供します。

研究はどのように設計されていますか?

デザインの詳細

  • 主な目的:基礎科学
  • 割り当て:ランダム化
  • 介入モデル:クロスオーバー割り当て
  • マスキング:独身

武器と介入

参加者グループ / アーム
介入・治療
実験的:TMS group

Transcranial Magnetic Stimulation (TMS) Stimulation Condition

Transcranial magnetic stimulation was applied to the dorsolateral prefrontal cortex (DLPFC), targeting the F3 site based on the international 10-20 EEG system. Repetitive transcranial magnetic stimulation (rTMS) was delivered at a frequency of 10 Hz with an intensity of 80% of the resting motor threshold (RMT). The stimulation protocol consisted of 30-second stimulation periods followed by 30-second inter-train intervals, with 15 repeated stimulation cycles and a total of 4,500 pulses. No concurrent tACS stimulation was applied during this condition.

実験的:tACS group

Transcranial Alternating Current Stimulation (tACS) Stimulation Condition

Transcranial alternating current stimulation (tACS) was applied to the dorsolateral prefrontal cortex (DLPFC), targeting the F3 site according to the international 10-20 EEG system. The stimulation intensity was set at 1 mA and continuously delivered for 15 minutes, including 5-second ramp-up and ramp-down periods. No concurrent transcranial magnetic stimulation was applied during this condition.

実験的:TMS-tACS combined stimulation group

Combined TMS-tACS Stimulation Condition

Combined transcranial magnetic stimulation and transcranial alternating current stimulation (TMS-tACS) were applied to the dorsolateral prefrontal cortex (DLPFC) targeting the F3 site according to the international 10-20 EEG system. Repetitive transcranial magnetic stimulation (rTMS) was delivered at a frequency of 10 Hz with an intensity of 80% of the resting motor threshold (RMT). The stimulation protocol consisted of 30-second stimulation periods followed by 30-second intervals, with 15 repeated stimulation cycles and a total of 4,500 pulses. Transcranial alternating current stimulation (tACS) was applied simultaneously with an intensity of 1 mA for 15 minutes, including 5-second ramp-up and ramp-down periods. During combined stimulation, TMS pulses were triggered at the peak phase of the tACS sinusoidal waveform to achieve phase-synchronized neuromodulation.

偽コンパレータ:Sham stimulation group

Sham Stimulation Condition

A sham stimulation condition was applied to simulate the sensory experience of active TMS-tACS stimulation without delivering effective neuromodulation. During sham tACS, electrical current was briefly delivered at the beginning of stimulation to mimic the initial skin sensation, while sham TMS was performed using prerecorded stimulation sounds to reproduce the auditory experience associated with active stimulation. No effective magnetic or electrical stimulation was delivered.

この研究は何を測定していますか?

主要な結果の測定

結果測定
メジャーの説明
時間枠
Heart-Brain Coupling (Modulation Index)
時間枠:At baseline (before stimulation), immediately after stimulation (T0), and approximately 60 minutes after stimulation (T60), during 10-minute resting-state recordings.

Simultaneous electroencephalography (EEG) and electrocardiography (ECG) data will be recorded. Heart-brain coupling will be quantified using the Modulation Index (MI) to assess the coupling between cardiac rhythms and cortical oscillatory activity. MI is a dimensionless index ranging from 0 to 1, with higher values indicating stronger coupling.

At baseline (before stimulation), immediately after stimulation (T0), and approximately 60 minutes after stimulation (T60), during 10-minute resting-state recordings.
Respiration-Brain Coupling (Modulation Index)
時間枠:At baseline (before stimulation), immediately after stimulation (T0), and approximately 60 minutes after stimulation (T60), during 10-minute resting-state recordings.

Simultaneous electroencephalography (EEG) and respiratory signals will be recorded. Respiration-brain coupling will be quantified using the Modulation Index (MI) to assess the coupling between respiratory rhythms and cortical oscillatory activity. MI is a dimensionless index ranging from 0 to 1, with higher values indicating stronger coupling.

At baseline (before stimulation), immediately after stimulation (T0), and approximately 60 minutes after stimulation (T60), during 10-minute resting-state recordings.
Gastric-Brain Coupling (Modulation Index)
時間枠:At baseline (before stimulation), immediately after stimulation (T0), and approximately 60 minutes after stimulation (T60), during 10-minute resting-state recordings.

Simultaneous electroencephalography (EEG) and electrogastrography (EGG) data will be recorded. Gastric-brain coupling will be quantified using the Modulation Index (MI) to assess the coupling between gastric electrical rhythms and cortical oscillatory activity. MI is a dimensionless index ranging from 0 to 1, with higher values indicating stronger coupling.

At baseline (before stimulation), immediately after stimulation (T0), and approximately 60 minutes after stimulation (T60), during 10-minute resting-state recordings.

二次結果の測定

結果測定
メジャーの説明
時間枠
Heart-Brain Coupling (Phase-Locking Value)
時間枠:At baseline (before stimulation), immediately after stimulation (T0), and approximately 60 minutes after stimulation (T60), during 10-minute resting-state recordings.

Simultaneous EEG and ECG signals will be recorded. Heart-brain phase synchronization will be quantified using the phase-locking value (PLV), which measures the consistency of phase differences between cardiac-related rhythms and cortical oscillations. PLV ranges from 0 to 1, with higher values indicating stronger phase synchronization.

At baseline (before stimulation), immediately after stimulation (T0), and approximately 60 minutes after stimulation (T60), during 10-minute resting-state recordings.
Heart-Brain Coupling (Mean Vector Length)
時間枠:At baseline (before stimulation), immediately after stimulation (T0), and approximately 60 minutes after stimulation (T60), during 10-minute resting-state recordings.

Simultaneous EEG and ECG signals will be recorded. Heart-brain coupling will be assessed using the mean vector length (MVL), which quantifies the relationship between cardiac-related phase and cortical oscillatory amplitude. Higher MVL values indicate stronger phase-amplitude coupling.

At baseline (before stimulation), immediately after stimulation (T0), and approximately 60 minutes after stimulation (T60), during 10-minute resting-state recordings.
Respiration-Brain Coupling (Phase-Locking Value)
時間枠:At baseline (before stimulation), immediately after stimulation (T0), and approximately 60 minutes after stimulation (T60), during 10-minute resting-state recordings.

Simultaneous EEG and respiratory signals will be recorded. Respiration-brain phase synchronization will be quantified using the phase-locking value (PLV), which measures the consistency of phase differences between respiratory rhythms and cortical oscillations. PLV ranges from 0 to 1, with higher values indicating stronger phase synchronization.

At baseline (before stimulation), immediately after stimulation (T0), and approximately 60 minutes after stimulation (T60), during 10-minute resting-state recordings.
Respiration-Brain Coupling (Mean Vector Length)
時間枠:At baseline (before stimulation), immediately after stimulation (T0), and approximately 60 minutes after stimulation (T60), during 10-minute resting-state recordings.

Simultaneous EEG and respiratory signals will be recorded. Respiration-brain coupling will be assessed using the mean vector length (MVL), which quantifies the relationship between respiratory phase and cortical oscillatory amplitude. Higher MVL values indicate stronger phase-amplitude coupling.

At baseline (before stimulation), immediately after stimulation (T0), and approximately 60 minutes after stimulation (T60), during 10-minute resting-state recordings.
Gastric-Brain Coupling (Phase-Locking Value)
時間枠:At baseline (before stimulation), immediately after stimulation (T0), and approximately 60 minutes after stimulation (T60), during 10-minute resting-state recordings.

Simultaneous EEG and EGG signals will be recorded. Gastric-brain phase synchronization will be quantified using the phase-locking value (PLV), which measures the consistency of phase differences between gastric electrical rhythms and cortical oscillations. PLV ranges from 0 to 1, with higher values indicating stronger phase synchronization.

At baseline (before stimulation), immediately after stimulation (T0), and approximately 60 minutes after stimulation (T60), during 10-minute resting-state recordings.
Gastric-Brain Coupling (Mean Vector Length)
時間枠:At baseline (before stimulation), immediately after stimulation (T0), and approximately 60 minutes after stimulation (T60), during 10-minute resting-state recordings.

Simultaneous EEG and EGG signals will be recorded. Gastric-brain coupling will be assessed using the mean vector length (MVL), which quantifies the relationship between gastric electrical phase and cortical oscillatory amplitude. Higher MVL values indicate stronger phase-amplitude coupling.

At baseline (before stimulation), immediately after stimulation (T0), and approximately 60 minutes after stimulation (T60), during 10-minute resting-state recordings.
N-back Working Memory Task Performance (d-prime)
時間枠:After each stimulation session, during the post-stimulation cognitive assessment.

Working memory performance will be assessed using the N-back task. The sensitivity index (d-prime, d') will be calculated based on the hit rate and false alarm rate using signal detection theory. Higher d-prime values indicate better working memory performance and greater ability to discriminate target from non-target stimuli.

After each stimulation session, during the post-stimulation cognitive assessment.
Visuospatial Working Memory Task Accuracy
時間枠:After each stimulation session, during the post-stimulation cognitive assessment.

Visuospatial working memory performance will be assessed using a visuospatial memory task. Task accuracy will be calculated as the percentage of correct responses relative to the total number of responses. Accuracy ranges from 0% to 100%, with higher values indicating better visuospatial working memory performance.

After each stimulation session, during the post-stimulation cognitive assessment.

協力者と研究者

ここでは、この調査に関係する人々や組織を見つけることができます。

スポンサー

研究記録日

これらの日付は、ClinicalTrials.gov への研究記録と要約結果の提出の進捗状況を追跡します。研究記録と報告された結果は、国立医学図書館 (NLM) によって審査され、公開 Web サイトに掲載される前に、特定の品質管理基準を満たしていることが確認されます。

主要日程の研究

研究開始 (推定)

2026年12月15日

一次修了 (推定)

2027年4月1日

研究の完了 (推定)

2027年4月1日

試験登録日

最初に提出

2026年10月30日

QC基準を満たした最初の提出物

2026年11月11日

最初の投稿 (実際)

2026年11月17日

学習記録の更新

投稿された最後の更新 (実際)

2026年11月17日

QC基準を満たした最後の更新が送信されました

2026年11月11日

最終確認日

2026年10月1日

詳しくは

本研究に関する用語

個々の参加者データ (IPD) の計画

個々の参加者データ (IPD) を共有する予定はありますか?

いいえ

医薬品およびデバイス情報、研究文書

米国FDA規制医薬品の研究

いいえ

米国FDA規制機器製品の研究

いいえ

この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。

購読する